Search Result "MHC-II"
Endothelial Expression of MHC Class II Molecules in Autoimmune Disease
Journal: Current Pharmaceutical Design
Volume: 10 Issue: 2 Year: 2004 Page: 129-143
Author(s): Carl Turesson
Structural Requirements for Binding of Myelin Basic Protein (MBP) Peptides to MHC II: Effects on Immune Regulation
Journal: Current Medicinal Chemistry
Volume: 12 Issue: 1 Year: 2005 Page: 1521-1535
Author(s): E. D. Mantzourani, T. M. Mavromoustakos, J. A. Platts, J. M. Matsoukas, T. V. Tselios
Inhibition of MHC II Gene Transcription by Nitric Oxide and Antioxidants
Journal: Current Pharmaceutical Design
Volume: 10 Issue: 8 Year: 2004 Page: 893-898
Author(s): Olivier Harari, James K. Liao
Use of MHC II Structural Features in the Design of Vaccines for Organ-Specific Autoimmune Diseases
Journal: Current Pharmaceutical Design
Volume: 15 Issue: 2 Year: 2009 Page: 3262-3273
Author(s): Antonis K. Moustakas, George K. Papadopoulos
GDF11 Attenuated ANG II-Induced Hypertrophic Cardiomyopathy and Expression of ANP, BNP and Beta-MHC Through Down- Regulating CCL11 in Mice
Journal: Current Molecular Medicine
Volume: 18 Issue: 10 Year: 2018 Page: 661-671
Author(s): Chenjun Zhang,Ying Wang,Zhiru Ge,Jie Lin,Jiwen Liu,Xiaofei Yuan,Zijun Lin
Docking Analysis of Deltamethrin Pesticide with MHC I and MHC IIMolecules to Establish Immunomodulation Effects
Journal: Current Signal Transduction Therapy
Volume: 18 Issue: 2 Year: 2023 Page: 60-67
Author(s):
In Silico and In Vitro Analysis of a Multiepitope L1-E7 Fusion Construct for Vaccine Development Against Human Papillomaviruses
Journal: Letters in Drug Design & Discovery
Volume: 18 Issue: 11 Year: 2021 Page: 1061-1093
Author(s): Elnaz Abbasifarid,Azam Bolhassani,Shiva Irani,Fattah Sotoodehnejadnematalahi
The Study of HLA Class II and Autoimmune Diabetes
Journal: Current Molecular Medicine
Volume: 3 Issue: 1 Year: 2003 Page: 1-15
Author(s): F. Susan Wong, Li Wen
Non-Canonical Peptides Bound to MHC
Journal: Current Pharmaceutical Design
Volume: 15 Issue: 2 Year: 2009 Page: 3274-3282
Author(s): Stephanie L. Day, Paul A. Ramsland, Vasso Apostolopoulos
MHC Class I TCR Engineered Anti-Tumor CD4 T Cells: Implications For Cancer Immunotherapy
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 9 Issue: 4 Year: 2009 Page: 344-352
Author(s): Arvind Chhabra